Exit Options for John Hancock Bond and Corporate Finance Group: Hanover Communications In... - 28 Strategic Investors

View x

Venture Capital firm Forbion Capital Partners invests $41 million in Spanish pharma company Laboratoris Sanifit SL

Leading Dutch Venture Capital Forbion Capital Partners has announced its investment in Spanish clinical-stage biopharmaceutical company Laboratoris Sanifit SL. This comes as part of Sanifit’s 36.6 million euro ($41 million) Series C financing round. Forbion has invested along with other investors lead by Ysios Capital including Lundbeckfond Ventures, Gilde Healthcare, Edmond de Rothschild Investment Partners and Baxter Healthcare. The funds raised through this fundraising will enable Sanifit to work on its lead drug candidate.


VC Deals,Forbion Capital Partners,Sanifit,Ysios Capital